Calcimedica, Common Stock Stock Price on November 15, 2024
CALC Stock | 2.78 0.03 1.07% |
Below is the normalized historical share price chart for CalciMedica, Common Stock extending back to September 25, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CalciMedica, Common stands at 2.78, as last reported on the 18th of December 2024, with the highest price reaching 2.84 and the lowest price hitting 2.71 during the day.
If you're considering investing in CalciMedica, Stock, it is important to understand the factors that can impact its price. CalciMedica, Common Stock secures Sharpe Ratio (or Efficiency) of -0.0808, which signifies that the company had a -0.0808% return per unit of risk over the last 3 months. CalciMedica, Common Stock exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CalciMedica, Common's Standard Deviation of 5.71, risk adjusted performance of (0.04), and Mean Deviation of 3.35 to double-check the risk estimate we provide.
At present, CalciMedica, Common's Common Stock is projected to decrease significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 12.6 M, whereas Total Stockholder Equity is forecasted to decline to about 7.7 M. . At present, CalciMedica, Common's Price To Book Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.65, whereas Price Earnings Ratio is forecasted to decline to (0.39). CalciMedica, Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2020 | 200 Day MA 4.368 | 50 Day MA 3.5855 |
CalciMedica, |
Sharpe Ratio = -0.0808
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CALC |
Estimated Market Risk
5.77 actual daily | 51 51% of assets are less volatile |
Expected Return
-0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CalciMedica, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CalciMedica, Common by adding CalciMedica, Common to a well-diversified portfolio.
Price Book 4.0759 | Book Value 1.417 | Enterprise Value 17.1 M | Enterprise Value Ebitda (0.26) | Shares Float 5.6 M |
CalciMedica, Common Valuation on November 15, 2024
It is possible to determine the worth of CalciMedica, Common on a given historical date. On November 15, 2024 CalciMedica, was worth 3.39 at the beginning of the trading date compared to the closed value of 3.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CalciMedica, Common stock. Still, in general, we apply an absolute valuation method to find CalciMedica, Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CalciMedica, Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CalciMedica, Common's related companies.
Open | High | Low | Close | Volume | |
3.45 | 3.45 | 3.35 | 3.37 | 32,498 | |
11/15/2024 | 3.39 | 3.44 | 3.27 | 3.33 | 69,836 |
3.38 | 3.43 | 3.30 | 3.38 | 36,768 |
Backtest CalciMedica, Common | | | CalciMedica, Common History | | | CalciMedica, Common Valuation | Previous | Next |
CalciMedica, Common Trading Date Momentum on November 15, 2024
On November 18 2024 CalciMedica, Common Stock was traded for 3.38 at the closing time. The top price for the day was 3.43 and the lowest listed price was 3.30 . The trading volume for the day was 36.8 K. The trading history from November 18, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 1.50% . The overall trading delta against the current closing price is 3.60% . |
CalciMedica, Common Stock Fundamentals Correlations and Trends
By evaluating CalciMedica, Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CalciMedica, Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CalciMedica, financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CalciMedica, Common Stock history
CalciMedica, Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CalciMedica, is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CalciMedica, Common Stock will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CalciMedica, Common stock prices may prove useful in developing a viable investing in CalciMedica, Common
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 4.5 M | 4.7 M | |
Net Loss | -13.1 M | -13.7 M |
CalciMedica, Common Quarterly Net Working Capital |
|
CalciMedica, Common Stock Technical Analysis
CalciMedica, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CalciMedica, Common Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
CalciMedica, Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CalciMedica, Common December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how CalciMedica, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CalciMedica, Common shares will generate the highest return on investment. By undertsting and applying CalciMedica, Common stock market strength indicators, traders can identify CalciMedica, Common Stock entry and exit signals to maximize returns
CalciMedica, Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CalciMedica, Common's price direction in advance. Along with the technical and fundamental analysis of CalciMedica, Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CalciMedica, to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.50) | |||
Total Risk Alpha | (0.88) | |||
Treynor Ratio | (0.35) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for CalciMedica, Stock analysis
When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stocks Directory Find actively traded stocks across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |